US2022288314A1PendingUtilityA1

Wearable medication delivery device

Assignee: INSULET CORPPriority: Nov 25, 2015Filed: May 26, 2022Published: Sep 15, 2022
Est. expiryNov 25, 2035(~9.3 yrs left)· nominal 20-yr term from priority
A61M 2205/52A61M 5/14248A61M 2205/3569A61M 5/14526A61M 5/14216A61M 2230/50A61M 2005/1585A61M 2005/14252A61M 2230/20A61M 2205/587A61M 2205/276A61M 2205/581A61M 2205/582A61M 2205/18A61M 2205/50A61M 2205/8206A61M 2205/502A61M 2205/0272A61M 5/1723A61M 2230/06A61M 2230/63A61M 2205/3368A61M 5/172A61M 2230/30A61M 2005/1586A61M 2230/201A61M 5/14A61M 5/1452A61M 2005/14204A61M 2205/583A61M 2005/14272A61M 5/158A61M 2205/0266A61M 2205/3303
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods for delivering a medication to a person experiencing an emergency medical event without requiring intervention or action on the part of the person. A device encases a reservoir of medication and a delivery mechanism. Sensors in the housing sense a physical attribute of the person and circuitry monitors information collected by the sensors to determine if the person is experiencing a severe medical condition or event based on the information. An input device on or in the housing, such as a button, may be used or activated by the person if the detected condition or event is a false positive to cancel further action. If the system does not include the button or if the user does not press it in time, the system activates the delivery device and injects the medication into the person.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An on-body drug delivery device, comprising:
 a reusable first portion including a motion sensor and a computer processor; and   a second portion including a needle, and a fluid reservoir for storing liquid medication,   wherein the first portion and the second portion are releasably attached to one another, the motion sensor is operable to capture acceleration information in three different axes and to be in electrical communication with the computer processor via a wired connection.   
     
     
         2 . The drug delivery device of  claim 1 , wherein the second portion further comprises:
 a power supply configured to supply power for a minimum amount of time, wherein the adhesive member has adhesive properties and the adhesive member is configured to lose some of its adhesive properties over the minimum amount of time.   
     
     
         3 . The on-body drug delivery device of  claim 2 , wherein the minimum amount of time that the adhesive member loses some of its adhesive properties is one day 
     
     
         4 . The on-body drug delivery device of  claim 1 , wherein the first portion further comprises:
 a power supply configured to supply power for a minimum amount of time, wherein the adhesive member has adhesive properties and the adhesive member is configured to lose some of its adhesive properties over the minimum amount of time.   
     
     
         5 . The on-body drug delivery device of  claim 3 , wherein the minimum amount of time that the adhesive member loses some of its adhesive properties is at least 2 days. 
     
     
         6 . The on-body drug delivery device of  claim 1 , wherein the second portion is configured to be disposable and the first portion is operable to be reusable with at least one new second portion. 
     
     
         7 . The on-body drug delivery device of  claim 1 , wherein the second portion further comprises:
 batteries and corresponding metal elements coupled to the batteries, wherein the first portion includes conducting metal elements that mate with the corresponding metal elements in the second portion.   
     
     
         8 . The on-body drug delivery device of  claim 1 , further comprises:
 if the first portion and the second portion are separated, the on-body drug delivery device is configured to be inoperable.   
     
     
         9 . The on-body drug delivery device of  claim 1 , wherein the fluid reservoir of the second portion is operable to dispense a quantity of liquid medication through the needle. 
     
     
         10 . The on-body drug delivery device of  claim 1 , wherein when the first portion and the second portion are releasably attached to one another, the first portion and the second portion are held together by a friction fit or by tabs. 
     
     
         11 . The on-body drug delivery device of  claim 1 , wherein when the first portion and the second portion are releasably attached to one another, one or both of the first portion. 
     
     
         12 . The on-body drug delivery device of  claim 1 , wherein the first portion and the second portion include a signal path then enables the computer processor of the first portion to communicate with the second portion. 
     
     
         13 . The on-body drug delivery device of  claim 1 , further comprising:
 a needle actuator configured to deploy the needle.   
     
     
         14 . The on-body drug delivery device of  claim 1 , further comprising:
 a plunger disposed in the fluid reservoir at an end of the reservoir opposite the needle and configured to advance within the reservoir toward the needle.   
     
     
         15 . The on-body drug delivery device of  claim 13 , further comprising:
 an electrochemical operable to exert a force on the plunger, wherein the force causes the plunger to advance toward the needle.   
     
     
         16 . The on-body drug delivery device of  claim 1 , wherein the reservoir further comprises:
 an elastic member that is configured to exert a force on any liquid medication stored in the reservoir.   
     
     
         17 . The on-body drug delivery device of  claim 1 , wherein the reservoir further comprises:
 a propellant that is configured to exert a force on any liquid medication stored in the reservoir.   
     
     
         18 . The on-body drug delivery device of  claim 1 , wherein:
 the needle is disposed within the on-body drug delivery device.   
     
     
         19 . The on-body drug delivery device of  claim 1 , further comprising:
 a spring positioned proximal to the needle and configured to force the needle into a body of a person upon activation.   
     
     
         20 . The on-body drug delivery device of  claim 19 , wherein the spring is compressed against a surface within the on-body housing.

Join the waitlist — get patent alerts

Track US2022288314A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.